Anne Vergison

3.4k total citations · 1 hit paper
47 papers, 2.0k citations indexed

About

Anne Vergison is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Anne Vergison has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 22 papers in Infectious Diseases and 9 papers in Microbiology. Recurrent topics in Anne Vergison's work include Pneumonia and Respiratory Infections (18 papers), Respiratory viral infections research (14 papers) and Viral gastroenteritis research and epidemiology (9 papers). Anne Vergison is often cited by papers focused on Pneumonia and Respiratory Infections (18 papers), Respiratory viral infections research (14 papers) and Viral gastroenteritis research and epidemiology (9 papers). Anne Vergison collaborates with scholars based in Belgium, United Kingdom and France. Anne Vergison's co-authors include Pierre R. Smeesters, Laurence Van Melderen, Olivier Denis, Marc Raes, Paola Marchisio, Marc Verghote, Pierre Van Damme, Koen Van Herck, Dioclécio Campos and Marc Struelens and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Anne Vergison

47 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg

2024 81 citations Dritan Bejko, Anne Vergison et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Vergison Belgium	25	875	874	393	345	322	47	2.0k
William J. Rodriguez United States	26	1.3k 1.5×	1.1k 1.3×	351 0.9×	207 0.6×	192 0.6×	59	2.5k
Hannu Sarkkinen Finland	26	700 0.8×	1.0k 1.2×	277 0.7×	146 0.4×	297 0.9×	68	1.9k
Basim I. Asmar United States	24	511 0.6×	693 0.8×	302 0.8×	258 0.7×	406 1.3×	97	1.8k
Jin Han Kang South Korea	24	693 0.8×	984 1.1×	114 0.3×	382 1.1×	243 0.8×	203	2.0k
Carmen Muñoz‐Almagro Spain	29	720 0.8×	2.2k 2.6×	441 1.1×	744 2.2×	355 1.1×	204	3.3k
Imad Kassis Israel	23	648 0.7×	967 1.1×	194 0.5×	207 0.6×	481 1.5×	110	2.3k
Rodrigo DeAntonio Panama	19	568 0.6×	633 0.7×	82 0.2×	202 0.6×	155 0.5×	63	1.3k
Ateş Kara Türkiye	22	547 0.6×	674 0.8×	148 0.4×	128 0.4×	282 0.9×	231	2.0k
William J. Rodríguez United States	21	828 0.9×	1.3k 1.5×	448 1.1×	199 0.6×	93 0.3×	42	2.1k
Hsin Chi Taiwan	29	919 1.1×	950 1.1×	513 1.3×	201 0.6×	454 1.4×	138	2.5k

Countries citing papers authored by Anne Vergison

Since Specialization

Citations

This map shows the geographic impact of Anne Vergison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Vergison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Vergison more than expected).

Fields of papers citing papers by Anne Vergison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Vergison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Vergison. The network helps show where Anne Vergison may publish in the future.

Co-authorship network of co-authors of Anne Vergison

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Vergison. A scholar is included among the top collaborators of Anne Vergison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Vergison. Anne Vergison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bejko, Dritan, et al.. (2024). High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis. Vaccine. 42(22). 126011–126011. 2 indexed citations

Pires‐Afonso, Yolanda, et al.. (2023). A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021. Geriatrics. 8(1). 19–19. 1 indexed citations

Mossong, Joël, et al.. (2023). Multisystem inflammatory syndrome in children during the first two years of the COVID-19 pandemic in Luxembourg. Frontiers in Pediatrics. 11. 1141074–1141074. 4 indexed citations

Duca, Radu Corneliu, Alícia Borràs-Santos, Emilie M. Hardy, et al.. (2022). Surveillance of Indoor Air Concentration of Volatile Organic Compounds in Luxembourgish Households. International Journal of Environmental Research and Public Health. 19(9). 5467–5467. 8 indexed citations

Schutter, Iris De, Anne Vergison, David Tuerlinckx, et al.. (2014). Pneumococcal Aetiology and Serotype Distribution in Paediatric Community-Acquired Pneumonia. PLoS ONE. 9(2). e89013–e89013. 18 indexed citations

Matthijnssens, Jelle, Mark Zeller, Elisabeth Heylen, et al.. (2014). Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. Clinical Microbiology and Infection. 20(10). O702–O710. 49 indexed citations

Madhi, Shabir A., Philippe De Wals, Carlos G. Grijalva, et al.. (2013). The Burden of Childhood Pneumonia in the Developed World: A Review of the Literature. Queensland's institutional digital repository (The University of Queensland). 7 indexed citations

Tuerlinckx, David, Julie Smet, Iris De Schutter, et al.. (2013). Evaluation of a WHO-validated Serotype-specific Serological Assay for the Diagnosis of Pneumococcal Etiology in Children With Community-acquired Pneumonia. The Pediatric Infectious Disease Journal. 32(7). e277–e284. 7 indexed citations

Esposito, Susanna, Robert Cohen, Javier Díez‐Domingo, et al.. (2012). Do We Know When, What and For How Long to Treat?. The Pediatric Infectious Disease Journal. 31(6). e78–e85. 87 indexed citations

10.

Madhi, Shabir A., Philippe De Wals, Carlos G. Grijalva, et al.. (2012). The Burden of Childhood Pneumonia in the Developed World. The Pediatric Infectious Disease Journal. 32(3). e119–e127. 60 indexed citations

11.

Vergison, Anne & Germaine Hanquet. (2012). Challenges in Estimating the Impact of Pneumococcal Conjugate Vaccines Through Surveillance. The Pediatric Infectious Disease Journal. 31(4). 400–403. 12 indexed citations

12.

Raes, Marc, et al.. (2011). Reduction in Pediatric Rotavirus-related Hospitalizations After Universal Rotavirus Vaccination in Belgium. The Pediatric Infectious Disease Journal. 30(7). e120–e125. 93 indexed citations

13.

Vergison, Anne, et al.. (2011). Heterogeneity of disease and clones of community-onset methicillin-resistant Staphylococcus aureus in children attending a paediatric hospital in Belgium. Clinical Microbiology and Infection. 18(8). 769–777. 4 indexed citations

14.

Blumental, Sophie, et al.. (2011). Enteroviral Infection of a Cardiac Prosthetic Device. Clinical Infectious Diseases. 52(6). 710–716. 5 indexed citations

15.

Hanquet, Germaine, G Ducoffre, Anne Vergison, et al.. (2011). Impact of rotavirus vaccination on laboratory confirmed cases in Belgium. Vaccine. 29(29-30). 4698–4703. 46 indexed citations

16.

Vergison, Anne, Ron Dagan, Adriano Arguedas, et al.. (2010). Otitis media and its consequences: beyond the earache. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 64 indexed citations

17.

Hanquet, Germaine, A Perrocheau, Esther Kissling, et al.. (2010). Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?. Vaccine. 28(23). 3920–3928. 23 indexed citations

18.

Vergison, Anne. (2008). Microbiology of otitis media: A moving target. Vaccine. 26. G5–G10. 93 indexed citations

19.

Smeesters, Pierre R., Patrick Mardulyn, Anne Vergison, Raphaël Leplae, & Laurence Van Melderen. (2008). Genetic diversity of Group A Streptococcus M protein: Implications for typing and vaccine development. Vaccine. 26(46). 5835–5842. 56 indexed citations

20.

Smeesters, Pierre R., et al.. (2006). Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape. PLoS ONE. 1(1). e10–e10. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact